What podcasts say about Sam Fazeli
Every statement, with the speaker, the exact quote and the moment it was said.
What Sam Fazeli has said on podcasts
19 statements · 12 positive · 6 negative · 1 mixed
AI can replace two or three contractors for some data-gathering tasks.
“i can displace two or three contractors, for instance, in some data gathering”
Open the episode · Episode 201 - October 30, 2026Listen at 14:48
Human review remains necessary to finalize AI-gathered data quality.
“I still need the human in the loop to finalize the quality of the data”
Open the episode · Episode 201 - October 30, 2026Listen at 14:56
A major Iran-related attack could raise oil prices and interest rates.
“a massive jump in oil prices could result in higher interest rates”
Open the episode · Episode 201 - October 30, 2026Listen at 28:14
Higher interest rates negatively affect biotech markets.
“interest rates, which we would love to believe that are not related, are not impacting biotech. But I think they do if they go high enough.”
Open the episode · Episode 201 - October 30, 2026Listen at 28:41
Amgen’s Delphi 305 data appeared practice-changing in small-cell lung cancer.
“I did see at least that as a practice-changing data set.”
Open the episode · Episode 201 - October 30, 2026Listen at 43:21
Delphi 305 is likely to change small-cell lung-cancer standard of care.
“this is standard of care changing.”
Open the episode · Episode 201 - October 30, 2026Listen at 49:45
Delphi 312 is expected to succeed after Delphi 305.
“I'm pretty convinced will be successful too”
Open the episode · Episode 201 - October 30, 2026Listen at 50:01
Ivanezumab improved overall and progression-free survival versus control.
“This hit both on overall survival and on progression-free survival.”
Open the episode · Episode 201 - October 30, 2026Listen at 52:30
Moderna’s valuation reflected substantial market expectations for its cancer vaccine.
“we're sitting here with revenue of what 2.2 2.3 billion dollars this year and therefore the amount of hope that's been pumped into this um story by the market um for the cancer vaccine is incredible”
Open the episode · Episode 200 - October 23, 2026Listen at 6:42
Market expectations for Moderna’s cancer vaccine became exceptionally high.
“the amount of hope that's been pumped into this um story by the market um for the cancer vaccine is incredible”
Open the episode · Episode 200 - October 23, 2026Listen at 6:48
Moderna’s valuation had reached a level requiring nearly perfect results.
“it was getting to a point where you needed absolute perfection”
Open the episode · Episode 200 - October 23, 2026Listen at 7:40
Moderna’s valuation had reached a level requiring near-perfect execution.
“you needed absolute perfection”
Open the episode · Episode 200 - October 23, 2026Listen at 7:41
Investors were seeking reasons to take profits after Moderna’s large increase.
“all that's going on here is people have tried to find a reason to to take profit for something that's gone up i don't know 200 300 400 depending where you measure it from”
Open the episode · Episode 200 - October 23, 2026Listen at 9:29
Biotech sector fundamentals are exceptionally strong.
“The fundamentals of the sector are phenomenal.”
Open the episode · Episode 200 - October 23, 2026Listen at 24:41
Biotech sector fundamentals are exceptionally strong despite external volatility.
“The fundamentals of the sector are phenomenal”
Open the episode · Episode 200 - October 23, 2026Listen at 24:41
Oncology will make substantial progress against difficult diseases, including GBM.
“i think that oncology would be again solving the diseases that they are difficult gbm potentially some of the smaller indications i think we'll see a lot of progress there”
Open the episode · Episode 200 - October 23, 2026Listen at 56:14
Oncology will make substantial progress against difficult diseases including GBM and smaller indications.
“oncology would be again solving the diseases that they are difficult gbm potentially some of the smaller indications”
Open the episode · Episode 200 - October 23, 2026Listen at 56:15
Cancer treatment will increasingly enable patients to live with cancer rather than die from it.
“a lot of people living with cancer as opposed to dying of it”
Open the episode · Episode 200 - October 23, 2026Listen at 56:26
Neurological diseases will eventually become treatable through major neuroscience advances.
“neuroscience i'm really looking forward to neurological diseases being finally cracked open and treated”
Open the episode · Episode 200 - October 23, 2026Listen at 56:30
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.